Abstract
Estrogen receptor (ER), one member of nuclear hormone receptor (NR) family, is an estrogen-dependent transcriptional factor that plays an important role in development, progression and treatment of breast cancer. Transcriptional co-factors (co-activators and co-repressors) are critical for ER to transduce hormone and metabolic signaling to target genes. A number of functional and structural studies have elucidated the precise mechanisms of co-activator interaction with the ligand-inducible activation domain in ER via one and several LXXLL motifs (where X is any amino acid) known as NR-Box. By the yeast two-hybrid system we have identified a novel ER-α interacting protein ERIAP (Estrogen Receptor Interacting and Activating Protein) which contains two consensus LXXLL motifs. ERIAP associated with ER-α in a ligand-dependent manner, as demonstrated by in vivo immunoprecipitation and in vitro GST capture assays. The two NR boxes were essential for ERIAP interaction with ER-α. Furthermore, ERIAP specifically enhanced ligand-mediated ER-α transcriptional activity in a dose-dependent fasion and increased the expression of estrogen-responsive gene pS2. Thus, our present findings indicate that ERIAP funcions as a new coactivator for ER-α transcriptional activity, which may play an important role in development and progression of breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gross, R. E., Breast cancer: Risk factors, screening, and prevention, Semin Oncol. Nurs., 2000, 16: 176–184.
Ferno, M., Borg, A., Johansson, U. et al., Estrogen and progesterone receptor analyses in more than 4000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses, Acta Oncol., 1990, 29: 129–135.
Dickson, R. B., Lippman, M. E., New approaches in the therapy of breast cancer—Introduction, Breast Cancer Res. Treat., 1996, 38: 1–2.
Katzenellenbogen, B. S., Katzenellenbogen, J. A., Estrogen receptor alpha and estrogen receptor beta: Regulation by selective estrogen receptor modulators and importance in breast cancer, Breast Cancer Res., 2000, 2: 335–344.
Russo, J., Hu, Y. F., Yang, X. et al., Developmental, cellular, and molecular basis of human breast cancer, J. Natl. Cancer Inst., 2000, 27: 17–37.
Beato, M., Herrlich, P., Schutz, G., Steroid hormone receptors: Many actors in search of a plot, Cell, 1995, 83: 851–857.
Truss, M., Beato, M., Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors, Endocr. Rev., 1993, 14: 459–479.
Tsai, M. J., O’Malley, B. W., Molecular mechanisms of action of steroid/thyroid receptor superfamily members, Annu. Rev. Biochem., 1994, 63: 451–486.
Mangelsdorf, D. J., Thummel, C., Beato, M. et al., The nuclear receptor superfamily: The second decade, Cell, 1995, 83: 835–839.
Kumar, V., Green, S., Stack, G. et al., Functional domains of the human estrogen receptor, Cell, 1987, 51: 941–951.
Gronemeyer, H., Transcription activation by estrogen and progesterone receptors, Annu. Rev. Genet., 1991, 25: 89–123.
Smith, C. L., Cross-talk between peptide growth factor and estrogen receptor signaling pathways, Biol. Reprod., 1998, 58: 627–632.
Tora, L., White, J., Brou, C. et al., The human estrogen receptor has two independent nonacidic transcriptional activation functions, Cell, 1989, 59: 477–487.
Webster, N. J., Green, S., Tasset, D. et al., The transcription activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded by a single exon, EMBO J., 1989, 8: 1441–1446.
Horwitz, K. B., Jackson, T. A., Bain, D. L. et al., Nuclear receptor coactivators and corepressors, Mol. Endocrinol., 1996, 10: 1167–1177.
McKenna, N., Lanz, R., O’Malley, B., Nuclear receptor coregulators: Cellular and molecular biology, Endocr. Rev., 1999, 20:321–344.
Glass, C. K., Rosenfeld, M. G., The coregulator exchange in transcriptional functions of nuclear receptors, Genes Dev., 2000, 14: 121–141.
Heery, D. M., Kalkhoven, E., Hoare, S. et al., A signature motif in transcriptional co-activators mediates binding to nuclear receptors, Nature, 1997, 387: 733–736.
He, B., Wilson, E. M., Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs, Mol. Cell Biol., 2003, 23: 2135–2150.
Gaughan, L., Brady, M. E., Cook, S. et al., Tip60 is a co-activator specific for class I nuclear hormone receptors, J. Biol. Chem., 2001, 276: 46841–46848.
Wong, C. W., Komm, B., Cheskis, B. J., Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators, ER selective ligands, Biochemistry, 2001, 40: 6756–6765.
Zhang, H., Thomsen, J. S., Johansson, L. et al., DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors, J. Biol. Chem., 2000, 275: 39855–39859.
Warnmark, A., Almlof, T., Leers, J. et al., Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta, J. Biol. Chem., 2001, 276: 23397–23404.
Gee, A. C., Carlson, K. E., Martini, P. G. et al., Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor, Mol. Endocrinol., 1999, 13: 1912–1923.
Schaufele, F., Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins, Mol. Endocrinol., 1999, 13: 935–945.
Kalkhoven, E., Valentine, J. E., Heery, D. M. et al., Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor, EMBO J., 1998, 17: 232–243.
McInerney, E. M., Rose, D. W., Flynn, S. E. et al., Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation, Genes Dev., 1998, 12: 3357–3368.
Fan, S., Wang, J., Meng, Q. et al., BRCA1 inhibits estrogen receptor signaling in transfected cells, Science, 1999, 284: 1354–1356.
Fan, S., Wang, J., Ma, Y. X. et al., Role of direct interaction in BRCA1 inhibition of estrogen receptor activity, Oncogene, 2001, 22: 77–87.
Fan, S., Ma, Y. X., Yuan, R. et al., P300 modulates the BRCA1 inhibition of estrogen receptor activity, Cancer Res., 2002, 62: 141–151.
Fan, S., Yuan, R., Ma, Y. X. et al., Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1, Oncogene, 2001, 20: 8215–8235.
Benton, W. D., Davis, P. W., Screening λgt recombinant clones by hybridization to single plaques in situ, Science, 1977, 196: 180–182.
Sanger, F., Nicklen, S., Coulson, A. R., DNA sequencing with chain termination inhibitors, Proc. Natl. Acad. Sci. USA, 1977, 74: 5463–5467.
Fukushi, M., Dixon, J., Kimura, T. et al., Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression, FEBS Lett., 1999, 442: 83–88.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Meng, Q., Zhou, L., Cao, J. et al. Identification and function of coactivator of estrogen receptor: ERIAP. Sci. China Ser. C.-Life Sci. 46, 546–558 (2003). https://doi.org/10.1360/03yc0062
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1360/03yc0062